Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications

European Journal of Health Economics

Volumn 13, Issue 1, 2012, Pages 111-120

  Kontodimopoulos, Nick ^a   Pappa, Evelina ^a   Chadjiapostolou, Zinovia ^a,b   Arvanitaki, Eleni ^a,c   Papadopoulos, Angelos A ^a,d   Niakas, Dimitris ^a  

^a HELLENIC OPEN UNIVERSITY   (Greece)

^b Mamatseio General Hospital   (Greece)

^c Ag Varvara Health Centre   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

15D; Coronary heart disease; Diabetes; EQ 5D; Retinopathy; Sensitivity; SF 6D; Utilities

Indexed keywords

15D; ADULT; AGED; ARTHROPATHY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC RETINOPATHY; EQ 5D; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SF 6D;

ADULT; AGED; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GREECE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84857782006     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-010-0290-y     Document Type: Article

References (59)

1. Wild, S., Roglic, G., Green, A., Sicree, R., King, H.: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053 (2004)
2. Stumvoll, M., Goldstein, B.J., van Haeften, T.W.: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346 (2005)
3. Massi-Benedetti, M.: The cost of diabetes type II in Europe. The CODE-2 Study. Diabetologia 4, S1-S4 (2002)
4. Centers for Disease Control and Prevention: National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta (2008)
5. Holmes, J., McGill, S., Kind, P., Bottomley, J., Gillam, S., Murphy, M.: Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health 3(1), 47-51 (2000)
6. Watkins, K., Connell, C.M.: Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics 22, 1109-1126 (2004)
7. Rose, M., Burkert, U., Scholler, G., Schirop, T., Danzer, G., Klapp, B.F.: Determinants of quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 21, 1876-1885 (1998)
8. Rubin, R.R., Peyrot, M.: Quality of life and diabetes. Diabetes Metab. Res. Rev. 15, 205-218 (1999)
9. Anderson, R.M., Fitzgerald, J.T., Wisdom, K., Davis, W.K., Hiss, R.G.: A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 20, 299-305 (1997)
10. Woodcock, A.J., Julious, S.A., Kinmonth, A.L., Campbell, M.J.: Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual. Life Res. 10, 661-670 (2001)
11. Parkerson Jr., G.R., Connis, R.T., Broadhead, W.E., Patrick, D.L., Taylor, T.R., Tse, C.K.: Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med. Care 31, 629-639 (1993)
12. Brooks, R.: EuroQol: the current state of play. Health Policy 37, 53-72 (1996)
13. Dolan, P., Gudex, C., Kind, P., Williams, A.: The time trade-off method: results from a general population study. Health Econ. 5, 141-154 (1996)
14. Yfantopoulos, J.: The Greek version of the EuroQol (EQ-5D) instrument. Arch. Hell. Med. 18, 180-191 (2001)
15. Kontodimopoulos, N., Pappa, E., Niakas, D., Yfantopoulos, J., Dimitrakaki, C., Tountas, Y.: Validity of the EQ-5D instrument in a Greek general population. Value Health 11, 1162-1169 (2008)
16. Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21, 271-292 (2002)
17. Pappa, E., Kontodimopoulos, N., Niakas, D.: Validating and norming of the Greek SF-36 Health Survey. Qual. Life Res. 14, 1433-1438 (2005)
18. Anagnostopoulos, F., Niakas, D., Pappa, E.: Construct validation of the Greek SF-36 Health Survey. Qual. Life Res. 14, 1959-1965 (2005)
19. Kontodimopoulos, N., Niakas, D.: A cost-utility analysis in renal replacement therapy based on patients' expected remaining life years. Health Policy 86, 85-96 (2008)
20. Kontodimopoulos, N., Pappa, E., Papadopoulos, A.A., Tountas, Y., Niakas, D.: Comparing SF-6D and EQ-5D utilities across groups differing in health status. Qual. Life Res. 18, 87-97 (2009)
21. Sintonen, H.: The 15D Instrument of health-related quality of life: properties and applications. Ann. Med. 33, 328-336 (2001)
22. Yfantopoulos, J.: Validation and measurement of quality of life in Greece using EQ-15D. Arch. Hell. Med. 18, 279-287 (2001)
23. Aletras, V.H., Kontodimopoulos, N., Niakas, D.A., Vagia, M.G., Pelteki, H.J., Karatzoglou, G.I., et al.: Valuation and preliminary validation of the Greek 15D in a sample of patients with coronary artery disease. Value Health 12, 574-579 (2009)
24. Lewis, K.S., Bradley, C., Knight, G., Boulton, A.J., Ward, J.D.: A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet. Med. 5, 235-242 (1988)
25. Stavem, K., Froland, S.S., Hellum, K.B.: Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Qual. Life Res. 14, 971-980 (2005)
26. Kontodimopoulos, N., Aletras, V.H., Paliouras, D., Niakas, D.: Mapping the cancer-specific EORTC QLQ-C30 instrument to preference-based EQ-5D, SF-6D and 15D indices. Value Health 12, 1151-1157 (2009)
27. Lillegraven, S., Kristiansen, I.S., Kvien, T.K.: Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Ann. Rheum. Dis. 69, 1762-1767 (2010)
28. Barton, G.R., Sach, T.H., Avery, A.J., Jenkinson, C., Doherty, M., Whynes, D.K., et al.: A comparison of the performance of the EQ-5D and SF-6D for individuals aged C45 years. Health Econ. 17, 815-832 (2008)
29. Drummond, M.F.: Introducing economic and quality of life measures into clinical studies. Ann. Med. 33, 344-349 (2001)
30. de Groot, V., Beckerman, H., Lankhorst, G.J., Bouter, L.M.: How to measure comorbidity. A critical review of available methods. J. Clin. Epidemiol. 56, 221-229 (2003)
31. Xuan, J., Kirchdoerfer, L.J., Boyer, J.G., Norwood, G.J.: Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data. Clin. Ther. 21, 383-403 (1999)
32. de Visser, C.L., Bibo, H.J., Groenier, K.H., de Visser, W., Jong Meyboom-de, B.: The influence of cardiovascular disease on quality of life in type 2 diabetics. Qual. Life Res. 11, 249-261 (2002)
33. Lloyd, A., Sawyer, W., Hopkinson, P.: Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 4, 392-400 (2001)
34. Wee, H.L., Cheung, Y.B., Li, S.C., Fong, K.Y., Thumboo, J.: The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts? Health Qual. Life Outcomes 3, 2 (2005)
35. Rose, M., Burkert, U., Scholler, G., Schirop, T., Danzer, G., Klapp, B.F.: Determinants of the quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 21, 1876-1885 (1998)
36. Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 12, 1061-1067 (2003)
37. Gerard, K., Nicholson, T., Mullee, M., Mehta, R., Roderick, P.: EQ-5D versus SF-6D in an older, chronically ill patient group. Appl. Health Econ. Health Policy 3, 91-102 (2004)
38. Lamers, L.M., Bouwmans, C.A., van Straten, A., Donker, M.C., Hakkaart, L.: Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ. 15, 1229-1236 (2006)
39. Xie, F., Li, S.C., Luo, N., Lo, N.N., Yeo, S.J., Yang, K.Y., et al.: Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis Rheum. 57, 1043-1049 (2007)
40. van Stel, H.F., Buskens, E.: Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual. Life Outcomes 4, 20 (2006)
41. Grieve, R., Grishchenko, M., Cairns, J.: SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. Eur. J Health Econ. 10, 15-23 (2004)
42. Brazier, J., Roberts, J., Tsuchiya, A., Busschbach, J.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13, 873-884 (2004)
43. Petrou, S., Hockley, C.: An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ. 14, 1169-1189 (2005)
44. Bharmal, M., Thomas 3rd, J.: Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9, 262-271 (2006)
45. Papadopoulos, A.A., Kontodimopoulos, M., Niakas, D.: Health related quality of life in type II diabetes patients: Assessing sociodemographic and clinical variables. In: Hoffmann, E.C. (ed.) Health-Related Quality of Life. Nova Science, New York (2009)
46. Papadopoulos, A.A., Kontodimopoulos, N., Frydas, A., Ikonomakis, E., Niakas, D.: Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health 7, 186 (2007)
47. Dennett, S.L., Boye, K.S., Yurgin, N.R.: The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health 11, 478-486 (2008)
48. Redekop, W.K., Koopmanschap, M.A., Stolk, R.P., Rutten, G.E., Wolffenbuttel, B.H., Niessen, L.W.: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 25, 458-463 (2002)
49. Nicolucci, A., Cucinotta, D., Squatrito, S., Lapolla, A., Musacchio, N., Leotta, S., et al.: Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 19, 45-53 (2009)
50. Wandell, P.E.: Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand. J. Prim. Health Care 23, 68-74 (2005)
51. U.K. Prospective Diabetes Study Group: Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 22, 1125-1136 (1999)
52. Wandell, P., Brorsson, B., Aberg, H.: Functioning and wellbeing of patients with type 2 diabetes or angina pectoris, compared with the general population. Diabetes Metab. 26, 465-471 (2000)
53. Ahola, A.J., Saraheimo, M., Forsblom, C., Hietala, K., Sintonen, H., Groop, P.H., et al.: Health-related quality of life in patients with type 1 diabetes-association with diabetic complications (the FinnDiane Study). Nephrol. Dial. Transplant. 25, 1903-1908 (2010)
54. Halkoaho, A., Kavilo, M., Pietilä, A.M., Huopio, H., Sintonen, H., Heinonen, S.: Does gestational diabetes affect women's health-related quality of life after delivery? Eur. J. Obstet. Gynecol. Reprod. Biol. 148, 20-43 (2010)
55. Patrick, D.L., Deyo, R.A.: Generic and disease-specific measures in assessing health status and quality of life. Med. Care 27(3 Suppl), S217-S232 (1989)
56. Bryan, S., Longworth, L.: Measuring health-related utility: why the disparity between EQ-5D and SF-6D? Eur. J. Health Econ. 6, 253-260 (2005)
57. Solli, O., Stavem, K., Kristiansen, I.S.: Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual. Life Outcomes 8, 18 (2010)
58. Hahl, J., Hämäläinen, H., Sintonen, H., Simell, T., Arinen, S., Simell, O.: Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Qual. Life Res. 11, 427-436 (2002)
59. Lubetkin, E.I., Jia, H., Franks, P., Gold, M.R.: Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: Examining the EQ-5D in the U.S. general population. Qual. Life Res 14, 2187-2196 (2005)